Clinical Trials Directory

Trials / Completed

CompletedNCT04740008

Impact of Low Nicotine Cigarette Messaging on Perceptions and Cigarette Choices

Impact of Low Nicotine Cigarette Messaging on Risk Perceptions and Hypothetical Tobacco and Nicotine Product Choices.

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
64 (actual)
Sponsor
Masonic Cancer Center, University of Minnesota · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Accepted

Summary

The purpose of this research is to evaluate the effects of low nicotine content cigarette (LNC) educational messaging on perceptions of low nicotine cigarettes, tobacco/nicotine product choice preferences (hypothetical), LNC cigarette subjective ratings, and LNC cigarette abuse liability among adult smokers.

Detailed description

This randomized single-site study will assess the subject's risk perceptions and hypothetical tobacco product choices based on their exposure to an educational messaging condition related to nicotine content in cigarettes. Subjects (N=40 in each group) will be given a pack of low nicotine content cigarettes (LNC; 0.4 mg/g) and will be randomly assigned to read one of two messaging conditions on low nicotine cigarettes. Smokers will undergo a telephone screening to assess eligibility, then move on to the next steps of the study depending on eligibility: 1. Virtual Zoom Screening - Completed after telephone screen: Informed consent is obtained and then an interview where data is collected and eligibility is further assessed. 2. Curbside Visit - Completed after the screening and if eligible: Breath test, and if necessary a urine test, is performed to assess smoking levels and urine pregnancy test is attained (if applicable). If eligible, randomization to messaging condition occurs and participants provided a pack of low nicotine content cigarettes. 3. Virtual Zoom Home Session - Completed after curbside and if eligible based on curbside: Surveys assessing main outcome variables assessed. 4. Follow-up - Completed 1 week after the virtual Zoom session: Interview where assessment of health and product usage is assessed. Except for the initial telephone screening, participants will receive compensation for each part of the study.

Conditions

Interventions

TypeNameDescription
DRUGLow Nicotine Content CigarettesLow Nicotine Content Cigarettes 0.4 mg/g nicotine; 9 mg tar Other Name: Reduced Nicotine Content Cigarettes
OTHERControl messageParticipants will read control message
OTHERTest messageParticipants will read test message

Timeline

Start date
2021-04-20
Primary completion
2022-08-24
Completion
2022-08-24
First posted
2021-02-05
Last updated
2024-02-26

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04740008. Inclusion in this directory is not an endorsement.